Whitehawk Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 2.17866675
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

1.79 0.02 (1.13%)

53.02% Fall from 52W High

55,637

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Whitehawk Therapeutics Inc. is on 07 Aug 2025 for the purpose of Aadi Bioscience Inc Second Quarter Earnings Results for 2025 See details